{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:24:14Z","timestamp":1772623454176,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200887"],"award-info":[{"award-number":["82200887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008868","name":"Jiangsu Science and Technology Department","doi-asserted-by":"crossref","award":["BK20220716"],"award-info":[{"award-number":["BK20220716"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M711404"],"award-info":[{"award-number":["2022M711404"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00277-023-05590-y","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T05:02:00Z","timestamp":1703653320000},"page":"1241-1254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy"],"prefix":"10.1007","volume":"103","author":[{"given":"Bihui","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangdi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaixin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiale","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haorui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"issue":"1","key":"5590_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57(1):43\u201366","journal-title":"CA Cancer J Clin"},{"issue":"10129","key":"5590_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","volume":"391","author":"M Hallek","year":"2018","unstructured":"Hallek M, Shanafelt TD, Eichhorst B (2018) Chronic lymphocytic leukaemia. Lancet 391(10129):1524\u20131537","journal-title":"Lancet"},{"issue":"25","key":"5590_CR3","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D et al (2018) iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131(25):2745\u20132760","journal-title":"Blood"},{"issue":"9","key":"5590_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/cncr.31931","volume":"125","author":"S Sharma","year":"2019","unstructured":"Sharma S, Rai KR (2019) Chronic lymphocytic leukemia (CLL) treatment: so many choices, such great options. Cancer 125(9):1432\u20131440","journal-title":"Cancer"},{"issue":"26","key":"5590_CR5","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1182\/blood.2021013435","volume":"138","author":"C Moreno","year":"2021","unstructured":"Moreno C, Mora A (2021) MRD in CLL: some answers, many questions. Blood 138(26):2746\u20132747","journal-title":"Blood"},{"issue":"1","key":"5590_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"issue":"2","key":"5590_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H (2016) Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci 73(2):377\u2013392","journal-title":"Cell Mol Life Sci"},{"key":"5590_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fgene.2018.00405","volume":"9","author":"M Maher","year":"2018","unstructured":"Maher M, Diesch J, Casquero R, Buschbeck M (2018) Epigenetic-transcriptional regulation of fatty acid metabolism and its alterations in leukaemia. Front Genet 9:405","journal-title":"Front Genet"},{"key":"5590_CR9","doi-asserted-by":"crossref","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z (2021) Lipid metabolism and cancer. J Exp Med 218(1):e20201606","DOI":"10.1084\/jem.20201606"},{"key":"5590_CR10","doi-asserted-by":"publisher","first-page":"902143","DOI":"10.3389\/fimmu.2022.902143","volume":"13","author":"F Jiang","year":"2022","unstructured":"Jiang F, Luo F, Zeng N et al (2022) Characterization of fatty acid metabolism-related genes landscape for predicting prognosis and aiding immunotherapy in glioma patients. Front Immunol 13:902143","journal-title":"Front Immunol"},{"key":"5590_CR11","doi-asserted-by":"publisher","first-page":"100822","DOI":"10.1016\/j.drup.2022.100822","volume":"61","author":"M Pi","year":"2022","unstructured":"Pi M, Kuang H, Yue C et al (2022) Targeting metabolism to overcome cancer drug resistance: a promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resist Updat 61:100822","journal-title":"Drug Resist Updat"},{"issue":"4","key":"5590_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3109\/10428194.2015.1106533","volume":"57","author":"U Rozovski","year":"2016","unstructured":"Rozovski U, Hazan-Halevy I, Barzilai M, Keating MJ, Estrov Z (2016) Metabolism pathways in chronic lymphocytic leukemia. Leuk Lymphoma 57(4):758\u2013765","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"5590_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1158\/1541-7786.MCR-14-0412","volume":"13","author":"U Rozovski","year":"2015","unstructured":"Rozovski U, Grgurevic S, Bueso-Ramos C et al (2015) Aberrant LPL expression, driven by STAT3, mediates free fatty acid metabolism in CLL cells. Mol Cancer Res 13(5):944\u2013953","journal-title":"Mol Cancer Res"},{"issue":"2","key":"5590_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3945\/ajcn.117.155010","volume":"106","author":"KA Bertrand","year":"2017","unstructured":"Bertrand KA, Giovannucci E, Rosner BA, Zhang SM, Laden F, Birmann BM (2017) Dietary fat intake and risk of non-Hodgkin lymphoma in 2 large prospective cohorts. Am J Clin Nutr 106(2):650\u2013656","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"5590_CR15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3324\/haematol.2018.192526","volume":"103","author":"M Solans","year":"2018","unstructured":"Solans M, Castello A, Benavente Y et al (2018) Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study. Haematologica 103(11):1881\u20131888","journal-title":"Haematologica"},{"issue":"7","key":"5590_CR16","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.leu.2403748","volume":"19","author":"D Heintel","year":"2005","unstructured":"Heintel D, Kienle D, Shehata M et al (2005) High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 19(7):1216\u20131223","journal-title":"Leukemia"},{"issue":"1","key":"5590_CR17","first-page":"56","volume":"91","author":"MB Van't Veer","year":"2006","unstructured":"Van\u2019t Veer MB, Brooijmans AM, Langerak AW et al (2006) The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 91(1):56\u201363","journal-title":"Haematologica"},{"issue":"8","key":"5590_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3324\/haematol.2010.039396","volume":"96","author":"MA Kaderi","year":"2011","unstructured":"Kaderi MA, Kanduri M, Buhl AM et al (2011) LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica 96(8):1153\u20131160","journal-title":"Haematologica"},{"key":"5590_CR19","doi-asserted-by":"crossref","unstructured":"Prieto D, Oppezzo P. (2017) Lipoprotein lipase expression in chronic lymphocytic leukemia: new insights into leukemic progression. Molecules 22(12):2083","DOI":"10.3390\/molecules22122083"},{"issue":"5","key":"5590_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1751-553X.2008.01078.x","volume":"31","author":"W Xu","year":"2009","unstructured":"Xu W, Li JY, Shen QD, Wu YJ, Yu H, Fan L (2009) Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Lab Hematol 31(5):552\u2013559","journal-title":"Int J Lab Hematol"},{"key":"5590_CR21","doi-asserted-by":"crossref","unstructured":"Gao R, Du K, Liang J, et al. (2023) Low serum cholesterol level is a significant prognostic factor that improves CLL-IPI in chronic lymphocytic leukaemia. Int J Mol Sci 24(8):7396","DOI":"10.3390\/ijms24087396"},{"issue":"3","key":"5590_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ijc.31327","volume":"143","author":"R Gao","year":"2018","unstructured":"Gao R, Chen RZ, Xia Y et al (2018) Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia. Int J Cancer 143(3):466\u2013477","journal-title":"Int J Cancer"},{"key":"5590_CR23","doi-asserted-by":"crossref","unstructured":"International CLLIPIwg (2016) An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol. 17(6):779\u2013790.","DOI":"10.1016\/S1470-2045(16)30029-8"},{"issue":"17","key":"5590_CR24","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1158\/0008-5472.CAN-22-0917","volume":"82","author":"Z Yu","year":"2022","unstructured":"Yu Z, Zhou X, Wang X (2022) Metabolic reprogramming in hematologic malignancies: advances and clinical perspectives. Cancer Res 82(17):2955\u20132963","journal-title":"Cancer Res"},{"issue":"10","key":"5590_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Martinez-Reyes","year":"2021","unstructured":"Martinez-Reyes I, Chandel NS (2021) Cancer metabolism: looking forward. Nat Rev Cancer 21(10):669\u2013680","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5590_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-022-00292-z","volume":"11","author":"Y Nie","year":"2022","unstructured":"Nie Y, Yun X, Zhang Y, Wang X (2022) Targeting metabolic reprogramming in chronic lymphocytic leukemia. Exp Hematol Oncol 11(1):39","journal-title":"Exp Hematol Oncol"},{"key":"5590_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcancer.2016.07.005","volume":"39","author":"L Mansouri","year":"2016","unstructured":"Mansouri L, Papakonstantinou N, Ntoufa S, Stamatopoulos K, Rosenquist R (2016) NF-kappaB activation in chronic lymphocytic leukemia: a point of convergence of external triggers and intrinsic lesions. Semin Cancer Biol 39:40\u201348","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"5590_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M (2018) NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18(5):309\u2013324","journal-title":"Nat Rev Immunol"},{"key":"5590_CR29","doi-asserted-by":"publisher","first-page":"4074832","DOI":"10.1155\/2020\/4074832","volume":"2020","author":"W Huang","year":"2020","unstructured":"Huang W, Man Y, Gao C et al (2020) Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-kappaB signaling. Oxid Med Cell Longev 2020:4074832","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"5590_CR30","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang K, Wang X, Song C et al (2023) The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics 13(6):1774\u20131808","journal-title":"Theranostics"},{"issue":"3","key":"5590_CR31","doi-asserted-by":"publisher","first-page":"e89160","DOI":"10.1172\/jci.insight.89160","volume":"2","author":"D Howie","year":"2017","unstructured":"Howie D, Cobbold SP, Adams E et al (2017) Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. JCI Insight 2(3):e89160","journal-title":"JCI Insight"},{"issue":"10","key":"5590_CR32","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/cncr.25752","volume":"117","author":"L Weiss","year":"2011","unstructured":"Weiss L, Melchardt T, Egle A, Grabmer C, Greil R, Tinhofer I (2011) Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia. Cancer 117(10):2163\u20132169","journal-title":"Cancer"},{"issue":"9","key":"5590_CR33","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","volume":"121","author":"JC Riches","year":"2013","unstructured":"Riches JC, Davies JK, McClanahan F et al (2013) T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood 121(9):1612\u20131621","journal-title":"Blood"},{"issue":"26","key":"5590_CR34","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1182\/blood.2020005602","volume":"136","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Lam PY, Jiang H et al (2020) Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood 136(26):3004\u20133017","journal-title":"Blood"},{"key":"5590_CR35","doi-asserted-by":"publisher","first-page":"100718","DOI":"10.1016\/j.drup.2020.100718","volume":"53","author":"E Perez-Ruiz","year":"2020","unstructured":"Perez-Ruiz E, Melero I, Kopecka J, Sarmento-Ribeiro AB, Garcia-Aranda M, De Las RJ (2020) Cancer immunotherapy resistance based on immune checkpoints inhibitors: targets, biomarkers, and remedies. Drug Resist Updat 53:100718","journal-title":"Drug Resist Updat"},{"key":"5590_CR36","doi-asserted-by":"publisher","first-page":"101055","DOI":"10.1016\/j.plipres.2020.101055","volume":"80","author":"KC Corn","year":"2020","unstructured":"Corn KC, Windham MA, Rafat M (2020) Lipids in the tumor microenvironment: from cancer progression to treatment. Prog Lipid Res 80:101055","journal-title":"Prog Lipid Res"},{"issue":"12","key":"5590_CR37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","volume":"21","author":"AJ Hoy","year":"2021","unstructured":"Hoy AJ, Nagarajan SR, Butler LM (2021) Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer 21(12):753\u2013766","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"5590_CR38","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1158\/1078-0432.CCR-19-0551","volume":"25","author":"K Evans","year":"2019","unstructured":"Evans K, Duan J, Pritchard T et al (2019) OBI-3424, a novel AKR1C3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL. Clin Cancer Res 25(14):4493\u20134503","journal-title":"Clin Cancer Res"},{"issue":"5","key":"5590_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q, Bin C, Xue Q et al (2021) GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis. Cell Death Dis 12(5):426","journal-title":"Cell Death Dis"},{"key":"5590_CR40","doi-asserted-by":"crossref","unstructured":"Cheng B, Wang Y, Ayanlaja AA, et al (2022) Glutathione S-transferases S1, Z1 and A1 serve as prognostic factors in glioblastoma and promote drug resistance through antioxidant pathways. Cells 11(20):3232","DOI":"10.3390\/cells11203232"},{"key":"5590_CR41","doi-asserted-by":"publisher","first-page":"843515","DOI":"10.3389\/fimmu.2022.843515","volume":"13","author":"Y Tang","year":"2022","unstructured":"Tang Y, Tian W, Xie J et al (2022) Prognosis and dissection of immunosuppressive microenvironment in breast cancer based on fatty acid metabolism-related signature. Front Immunol 13:843515","journal-title":"Front Immunol"},{"key":"5590_CR42","doi-asserted-by":"crossref","unstructured":"Bamodu OA, Tzou KY, Lin CD, et al (2021) Differential but concerted expression of HSD17B2, HSD17B3, SHBG and SRD5A1 testosterone tetrad modulate therapy response and susceptibility to disease relapse in patients with prostate cancer. Cancers (Basel) 13(14):3478","DOI":"10.3390\/cancers13143478"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05590-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05590-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05590-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T10:08:06Z","timestamp":1710410886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05590-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["5590"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05590-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,27]]},"assertion":[{"value":"11 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). And written informed consent was obtained from all patients according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}